Perceptions of dengue risk and acceptability of a dengue vaccine in residents of Puerto Rico
Dengvaxia is the first dengue vaccine recommended in the United States (U.S.). It is recommended for children aged 9–16 y with laboratory-confirmed previous dengue infection and living in areas where dengue is endemic. We conducted focus groups with parents and in-depth interviews with key informant...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Taylor & Francis Group
2024-12-01
|
| Ráidu: | Human Vaccines & Immunotherapeutics |
| Fáttát: | |
| Liŋkkat: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2323264 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|